Published in Int J Cancer on October 15, 1990
Incidence of cancer among Finnish airline cabin attendants, 1967-92. BMJ (1995) 3.30
Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer (2015) 1.60
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.50
Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat (2002) 1.40
Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer (1996) 1.37
Oestrogen exposure and breast cancer risk. Breast Cancer Res (2003) 1.34
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer (2009) 1.22
Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest (2000) 1.18
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia. Br J Cancer (2005) 1.16
Reproductive history and breast cancer risk. Breast Cancer (2012) 1.14
Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer (1998) 1.10
Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med (2003) 1.09
Trends in breast cancer incidence in Sweden 1958-1988 by time period and birth cohort. Br J Cancer (1993) 1.04
Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer (2011) 1.00
The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies. Br J Cancer (1998) 0.94
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol (2008) 0.92
Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995. J Med Genet (1999) 0.90
Socio-economic status and overall and cause-specific mortality in Sweden. BMC Public Health (2008) 0.87
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol (2013) 0.86
Established and Suspected Risk Factors in Breast Cancer Aetiology. Breast Care (Basel) (2009) 0.86
Incidence of cancer among residents of high temperature geothermal areas in Iceland: a census based study 1981 to 2010. Environ Health (2012) 0.86
Occupation as a risk identifier for breast cancer. Am J Public Health (1993) 0.85
15. Cancers attributable to reproductive factors in the UK in 2010. Br J Cancer (2011) 0.85
Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors. Breast Cancer Res Treat (2015) 0.81
Breastfeeding reduces breast cancer risk: a case-control study in north India. Int J Prev Med (2014) 0.81
The pattern of risk factors for breast cancer in a southern France population. Interest for a stratified analysis by age at diagnosis. Br J Cancer (1991) 0.80
Female breast cancer incidence and survival in Utah according to religious preference, 1985-1999. BMC Cancer (2005) 0.80
Breast cancer incidence in a cohort of U.S. flight attendants. Am J Ind Med (2015) 0.79
Educational differences in postmenopausal breast cancer--quantifying indirect effects through health behaviors, body mass index and reproductive patterns. PLoS One (2013) 0.79
Familial risk, abortion and their interactive effect on the risk of breast cancer--a combined analysis of six case-control studies. Br J Cancer (1995) 0.79
Female breast cancer in Vietnam: a comparison across Asian specific regions. Cancer Biol Med (2015) 0.78
Breast cancer incidence subsequent to surgical reduction of the female breast. Br J Cancer (1996) 0.77
Glycoprotein components in the serum of patients with cancer breast. Indian J Clin Biochem (1997) 0.77
The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health (2012) 0.77
Folic acid in pregnancy and mortality from cancer and cardiovascular disease: further follow-up of the Aberdeen folic acid supplementation trial. J Epidemiol Community Health (2015) 0.76
Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis. Onco Targets Ther (2017) 0.75
Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40-49 years. J Midlife Health (2017) 0.75
Risk factors associated with a breast cancer in a population of Moroccan women whose age is less than 40 years: a case control study. Pan Afr Med J (2016) 0.75
Long working hours and cancer risk: a multi-cohort study. Br J Cancer (2016) 0.75
Prevalence of risk factors for breast cancer in German airline cabin crew: a cross-sectional study. J Occup Med Toxicol (2014) 0.75
Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk. PLoS One (2017) 0.75
Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile. Br J Cancer (2012) 0.75
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation. Oncotarget (2016) 0.75
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer (2001) 6.16
Consequences of assessment and intervention among elderly people: a three year randomised controlled trial. Br Med J (Clin Res Ed) (1984) 6.00
Physical activity and the risk of breast cancer. N Engl J Med (1997) 5.85
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet (1992) 5.20
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Hybridization of labeled RNA to DNA in agarose gels. Nucleic Acids Res (1975) 4.38
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet (1996) 4.38
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
tRNA genes are found between 16S and 23S rRNA genes in Bacillus subtilis. Nucleic Acids Res (1982) 3.93
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet (2000) 3.76
Stressful life events and Graves' disease. Lancet (1991) 3.63
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
3' end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell (1986) 3.61
The natural history of breast carcinoma: what have we learned from screening? Cancer (1999) 3.55
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer (1995) 3.32
Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem (1995) 3.19
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer (2007) 3.15
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J (1997) 3.10
Transcription of a gene for human U1 small nuclear RNA. Cell (1982) 2.93
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer (1997) 2.75
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science (1997) 2.72
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Transfer RNA genes between 16S and 23S rRNA genes in rRNA transcription units of E. coli. Cell (1976) 2.68
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen (2004) 2.62
The use of an aqueous polymer phase system for enterovirus isolations from sewage. Am J Epidemiol (1966) 2.60
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
Screening for cancer of the uterine cervix in Iceland 1965--1978. Acta Obstet Gynecol Scand (1982) 2.57
Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer (1977) 2.56
Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut (1983) 2.53
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
The two embryonic U1 RNA genes of Xenopus laevis have both common and gene-specific transcription signals. EMBO J (1985) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol (2001) 2.48
Early onset of breast cancer in a group of British black women. Br J Cancer (2008) 2.47
Synthesis of human U1 RNA. II. Identification of two regions of the promoter essential for transcription initiation at position +1. J Biol Chem (1984) 2.46
Predicting acute maxillary sinusitis in a general practice population. BMJ (1995) 2.44
Codon specific, tRNA dependent in vitro synthesis of ppGpp and pppGpp. Nat New Biol (1973) 2.36
True genes for human U1 small nuclear RNA. Copy number, polymorphism, and methylation. J Biol Chem (1984) 2.35
Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer (1994) 2.33
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31
Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet (1997) 2.28
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer (2003) 2.26
Suicide among women related to number of children in marriage. Arch Gen Psychiatry (1993) 2.23
European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr (2002) 2.23
Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst (1986) 2.23
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22
Metabolism of guanosine tetraphosphate in Escherichia coli. Eur J Biochem (1972) 2.22
The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21
The vertebrate GLFG nucleoporin, Nup98, is an essential component of multiple RNA export pathways. J Cell Biol (1997) 2.19
Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol (1975) 2.17
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol (1998) 2.05
A common maturation pathway for small nucleolar RNAs. EMBO J (1995) 2.02
[Meta-analysis is a good help for literature review. It makes the analysis of earlier studies more efficient and more objective]. Lakartidningen (1999) 2.02